The U.S. Food and Drug Administration (FDA) announced today that it is proposing a new rule to stop the use of an ingredient ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

Itchy eyes, rashes, sneezing, wheezing, swelling and shortness of breath are among the symptoms shared by about 50 million ...

But the ingredients list on many of these products might start to look very different based on new guidance from the Food and ...

make sure that your veterinarian is aware of this before beginning a new prescription medication. Allergy medications can ...

In the future, better identification of the undesirable immune response in individual patients will allow targeting of anti-inflammatory treatment with fewer side effects. Allergic conjunctivitis ...

The new study will investigate the performance ... OX640 is an intranasal rescue medication for the treatment of severe allergic reactions (incl. anaphylaxis) with powder-based epinephrine.

Peanut allergies affect about one million ... Selling Palforzia could actually make the treatment more widely available as a new company would seek to recruit as many patients as possible, said ...